Performance analysis of FibroBiologics (FBLG)
Annual Return
Since Jan 31, 2024, FBLG has had an average annual return of -93.23%, underperforming the benchmark SPY, which returned +20.45% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -83.12% | -88.79% | -93.13% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +48.05% | -0.88% | -79.65% | +0% | -13.04% | -20.00% | -18.75% | -83.12% | |||||
| 2025 | -19.51% | -21.70% | -28.64% | +24.60% | -34.81% | -14.74% | +2.34% | -7.31% | -7.39% | -28.19% | -30.37% | -18.09% | -88.79% |
| 2024 | +0% | -55.12% | -17.22% | -12.76% | +29.16% | -59.03% | +4.37% | -68.88% | +90.66% | -2.26% | -13.29% | -23.67% | -93.13% |
Drawdown analysis of FibroBiologics (FBLG)
The maximum drawdown for the FBLG was -99.87%, occurring on Jun 18, 2026. This drawdown has not yet recovered.
The current FBLG drawdown is -99.87%.
Since Jan 31, 2024 FBLG has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.87% | Jan 31, 2024 | 597 | Jun 18, 2026 | Ongoing | Ongoing | Ongoing |